Press "Enter" to skip to content

MDCG 2019-3 Interpretation of Article 54(2)b – Pre- market clinical evaluation consultation procedure with the involvement of expert panels

MDCG 2019-3 Interpretation of Article 54(2)b

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *